Search research articles
Contact Us
Filters
Showing results (501-510 of 631) with videos related to
Page
of 64
Sort By:
BMC Cancer
|
August 18, 2009
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2017
Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors
Anthony W Tolcher, Mario Sznol, Siwen Hu-Lieskovan, et al.
The Journal of Clinical Investigation
|
May 9, 2001
Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice
Y Imanishi, Y Hosokawa, K Yoshimoto, et al.
Nature Neuroscience
|
May 7, 2013
Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss
Xiao-Dong Wang, Yun-Ai Su, Klaus V Wagner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 17, 2010
Individual stress vulnerability is predicted by short-term memory and AMPA receptor subunit ratio in the hippocampus
Mathias V Schmidt, Dietrich Trümbach, Peter Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
Tara C Mitchell, Omid Hamid, David C Smith, et al.
Cancer Discovery
|
August 30, 2018
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Antoni Ribas, Theresa Medina, Shivaani Kummar, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
May 16, 2012
Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women
J Giacomazzi, E Aguiar, E I Palmero, et al.
Journal of Neuroendocrinology
|
May 24, 2019
Identification of mineralocorticoid receptor target genes in the mouse hippocampus
Lisa T C M van Weert, Jacobus C Buurstede, Hetty C M Sips, et al.
Journal of Medicinal Chemistry
|
November 22, 2025
Linker Modification Enables Control of Key Functional Group Orientation in Macrocycles
Christian Brudy, Enrico Ruijsenaars, Christian Meyners, et al.
Page
of 64
Search research articles
Search
Showing results (501-510 of 631) with videos related to
Sort By:
Page
of 64
BMC Cancer
|
August 18, 2009
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2017
Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors
Anthony W Tolcher, Mario Sznol, Siwen Hu-Lieskovan, et al.
The Journal of Clinical Investigation
|
May 9, 2001
Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice
Y Imanishi, Y Hosokawa, K Yoshimoto, et al.
Nature Neuroscience
|
May 7, 2013
Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss
Xiao-Dong Wang, Yun-Ai Su, Klaus V Wagner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 17, 2010
Individual stress vulnerability is predicted by short-term memory and AMPA receptor subunit ratio in the hippocampus
Mathias V Schmidt, Dietrich Trümbach, Peter Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
Tara C Mitchell, Omid Hamid, David C Smith, et al.
Cancer Discovery
|
August 30, 2018
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Antoni Ribas, Theresa Medina, Shivaani Kummar, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
May 16, 2012
Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women
J Giacomazzi, E Aguiar, E I Palmero, et al.
Journal of Neuroendocrinology
|
May 24, 2019
Identification of mineralocorticoid receptor target genes in the mouse hippocampus
Lisa T C M van Weert, Jacobus C Buurstede, Hetty C M Sips, et al.
Journal of Medicinal Chemistry
|
November 22, 2025
Linker Modification Enables Control of Key Functional Group Orientation in Macrocycles
Christian Brudy, Enrico Ruijsenaars, Christian Meyners, et al.
Page
of 64